Source: CURATED
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.500 | None | 0.979 | 1 | 19 | 2010 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.700 | None | 0.978 | 2 | 7 | 1990 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.500 | None | 1.000 | 0 | 10 | 2001 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2008 | 2020 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 2 | 14 | 2002 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.967 | 5 | 2 | 1990 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.500 | None | 0.987 | 0 | 6 | 1989 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.500 | None | 1.000 | 2 | 3 | 2008 | 2018 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.500 | None | 0.929 | 1 | 5 | 2010 | 2017 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.410 | None | 1.000 | 0 | 1 | 2008 | 2018 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.400 | None | 0.900 | 0 | 3 | 2009 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.923 | 1 | 9 | 1990 | 2016 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 2001 | 2019 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2009 | 2017 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.380 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.440 | None | 0.833 | 0 | 5 | 2008 | 2019 | ||||||||
|
lamin A/C | 0.384 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2017 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.420 | None | 1.000 | 0 | 2 | 2010 | 2016 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.650 | None | 1.000 | 0 | 1 | 2013 | 2018 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.700 | None | 0.977 | 8 | 6 | 2008 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 2011 | 2015 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2019 |